Email this article 
Hide
Show all
Editorial
Pharmaceutical Manufacturing Plan for Africa is critical for pandemic preparedness, prevention and response
Submitted: 14 March 2024 | Published: 30 November 2023
About the author(s)
Michael Mynhardt, Group Executive at Avacare Health Global, Managing Director at Barrs Pharmaceutical Industries (Pty) Ltd, South AfricaNicaise Ndembi, Office of The Director General of The Africa Center for Disease Control and Prevention (Africa CDC), Souh Africa
Full Text:
PDF (155KB)Abstract
No abstract available.
Keywords
Metrics
Total abstract views: 2438Total article views: 1421
Crossref Citations
1. The influence of institutional logics on vaccine development, production and distribution in Africa
Richard Chawana, Anastacia Mamabolo, Evangelos Apostoleris
International Journal of Operations & Production Management vol: 45 issue: 2 first page: 355 year: 2025
doi: 10.1108/IJOPM-11-2023-0896
2. Key challenges limiting local vaccine production in Nigeria: A quantitative study among industrial and regulatory pharmacists
Ukamaka Gladys Okafor, Ebele Eugenia Onwuchuluba, Joseph Michael Okwori, Oluebubechukwu Praise Eze, Unoma Ada Asomugha, Solomon Ukavenda Shiihii, Enayi Onaji
Vaccine: X first page: 100873 year: 2026
doi: 10.1016/j.jvacx.2026.100873
3. Rethinking corruption: a decolonial inquiry into the intersection of historical systems and anti-corruption efforts
Nana Koomson, Tolulope Ojo, Eustace Orleans-Lindsay, Andrea Bowra
Journal of Pharmaceutical Health Services Research vol: 16 issue: 3 year: 2025
doi: 10.1093/jphsr/rmaf010
4. The Need for Lenacapavir Compulsory Licences in Ending the HIV Epidemic
Andrew Hill, Mark J Siedner, Cassandra Fairhead, Francois Venter
Clinical Infectious Diseases vol: 81 issue: 3 first page: 547 year: 2025
doi: 10.1093/cid/ciaf115